Navigation Links
Optimer Reports Fourth Quarter and Fiscal Year 2011 Financial Results
Date:3/7/2012

dditional hospital formularies and the timing of hospital formulary decisions, Optimer's ability to successfully coordinate commercialization efforts with Cubist Pharmaceuticals under its co-promotion agreement, whether Optimer will be able to realize expected benefits under its co-promotion agreement with Cubist and its collaboration agreement with Astellas, the fact that past results may not be predictive of future results or performance, the possibility of alternative means of preventing or treating DIFICID impacting adoption and sales of DIFICID, Optimer's ability, through its third party manufacturers and logistics providers, to maintain a sufficient supply of DIFICID to meet demand, and other risks detailed in Optimer's filings with the Securities and Exchange Commission.  Forward-looking statements speak only as of the date of this release, and Optimer undertakes no obligation to update or revise these statements, except as may be required by law. Optimer Pharmaceuticals, Inc. Consolidated Statements of Operations Three Months Ended December 31, Year Ended December 31, 2011201020112010Revenues:Product revenue, net

$   10,959,217$
-$ 21,511,037$
-Licensing

53,584,000-122,749,000-Research grants and collaborative agreements

73,139156,352718,3361,480,362Total revenues

64,616,356156,352144,978,3731,480,362Operating expenses:Cost of product sales

909,843-1,525,798-Cost of licensing

3,310,821-7,584,353-Research and development

14,011,0596,940,56443,085,30732,797,672Selling, general and administrative

33,632,5915,706,45587,144,25717,550,883Total operating expenses

51,864,31412,647,019139,339,71550,348,555Income (loss) from operations

12,752,042(12,490,667)5,638,658(48,868,193)Interest income and other, net

63,337227,899290,870329,290Consolidated net income (loss)

$   12,815,379$(12,262,768)$   5,929,528$(48,538,903)Net loss attributable to noncontrolli
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and FY 2011 Financial Results
2. Optimer Pharmaceuticals to Present at the 32nd Annual Cowen Health Care Conference
3. Optimer Pharmaceuticals Provides Update on DIFICID® (fidaxomicin) Tablets Launch
4. Optimer Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
5. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
6. Optimer Pharmaceuticals to Present at BioCentury Newsmakers Conference
7. Optimer Pharmaceuticals and Astellas Receive Positive Opinion from CHMP for European Approval of DIFICID™
8. Optimer to Provide DIFICID™ Launch Update at Morgan Stanley Global Healthcare Conference
9. Optimer Pharmaceuticals DIFICID Featured in 11 Presentations at 51st ICAAC
10. Optimer Pharmaceuticals to Present at September 2011 Investor Conferences
11. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... SOUTH EASTON, Mass. , Sept. 19, 2014 ... the "Company") today announced it has received and ... throughput Barozyme HT48 instruments and has begun to ... believes the first instrument will be ready for ... will be built and released at a rate ...
(Date:9/19/2014)... , September 19, 2014 ... IQ den äußerst erfolgreichen Serialisierungs-Countdown-Kalender aktualisiert, der jetzt ... interaktive PDF, verfügbar unter pharmaserialisation.com , zeigt ... sie jeweils in Kraft treten. Für ... nicht länger um das "ob", sondern darum, "wann" ...
(Date:9/19/2014)... and CAMBRIDGE, Mass. ... Inc. (PGDx), a provider of advanced cancer ... Medicines , a leader in discovering and developing ... today disclosed the first-ever comprehensive genomic study of ... deadly cancer of the female reproductive system, also ...
Breaking Medicine Technology:Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 4
... Choice and Access Now (PCAN) – a coalition ... nation and Texas, committed to preserving quality and ... for the passage of Senate Bill 7, which ... for Texans and their community pharmacies.  Among these ...
... Lilly and Company (NYSE: LLY ) announced ... the Clinical Endocrinology website, showed that Axiron® (testosterone) topical ... primary study objective to restore testosterone levels to the ... low testosterone. In addition, secondary outcomes showed that the ...
Cached Medicine Technology:Pharmacy Choice and Access Now Coalition Applauds Passage of Senate Bill 7 During Texas Legislature's Special Session 2Newly Published Study Showed Axiron® (testosterone) Topical Solution Restored Testosterone Levels to Normal Range in Hypogonadal Men 2Newly Published Study Showed Axiron® (testosterone) Topical Solution Restored Testosterone Levels to Normal Range in Hypogonadal Men 3Newly Published Study Showed Axiron® (testosterone) Topical Solution Restored Testosterone Levels to Normal Range in Hypogonadal Men 4Newly Published Study Showed Axiron® (testosterone) Topical Solution Restored Testosterone Levels to Normal Range in Hypogonadal Men 5Newly Published Study Showed Axiron® (testosterone) Topical Solution Restored Testosterone Levels to Normal Range in Hypogonadal Men 6
(Date:9/19/2014)... Alan Mozes HealthDay ... -- Cancer patients burdened by stress and family conflicts ... following their operation, a new study suggests. Investigators ... to have a nearly three times greater risk for ... quality of life. "We,ve long known that patient ...
(Date:9/19/2014)... a leading anti-ageing clinic has called its HGH Therapy ... has grown tremendously across USA in the last decade with ... It has far reaching benefits for ageing men and women ... and active lifestyle even beyond their middle age. , ... MetroMD said, “HGH or Human Growth hormones are the building ...
(Date:9/19/2014)... September 19, 2014 In partnership with Raw ... an active part of the project’s social media efforts. StudioPMG ... aims to re-define the perception of beauty as it applies ... as an idea by Shelly Baer and Vanessa Silberman, who ... as sexy and beautiful. Ginny Dixon, Wendy Crawford, Susan Solman ...
(Date:9/19/2014)... Recent two-generation approaches to reducing poverty that help ... from researchers, advocates, and foundations. By combining education ... move to jobs that offer a path out ... for children, these programs aim to improve the ... a new report from the National Center for ...
(Date:9/19/2014)... NY (PRWEB) September 20, 2014 As summer ... Krishnan DMD in Queens, NY now reminds area patients about ... than 80% of our population affected by gum disease, there ... longer.” , For over 20 years Dr. Krishnan has treated ... Hills office location. “Most patients that come in due to ...
Breaking Medicine News(10 mins):Health News:Family Squabbles Can Derail Recovery From Cancer Surgery 2Health News:Family Squabbles Can Derail Recovery From Cancer Surgery 3Health News:MetroMD Announces Better HGH Therapy - the ‘God Particle’ of Human Health 2Health News:OC Healthcare Agency StudioPMG Partners with The Raw Beauty Project ™ NYC 2014 2Health News:A two generation lens: Current state policies fail to support families with young children 2Health News:New York Periodontist Dr. Prabha Krishnan Now Raises Awareness about the Dangers of Untreated Decay, Gingivitis and Gum Disease During Self-Awareness Month 2Health News:New York Periodontist Dr. Prabha Krishnan Now Raises Awareness about the Dangers of Untreated Decay, Gingivitis and Gum Disease During Self-Awareness Month 3
... , , , GLENVIEW, Ill., ... palliative medicine has launched a new Web site -- www.PalliativeDoctors.org ... and how it can help patients with serious illnesses, and their ... and Palliative Medicine (AAHPM) created www.PalliativeDoctors.org to meet a ...
... , , NORRISTOWN, Pa., Aug. 24 ... drugs for clinical research and clinical trials, has expanded ... new capability provides their clients with an efficient solution ... in clinical trials. Distribution Management Services is an ...
... , , , HACKENSACK, ... of The Prostate Net announced the organization,s latest major initiative ... symposium targeting patients, caregivers and medical professionals will take place ... Center for University Life in New York City. Joined ...
... , WASHINGTON, Aug. 24 Secretary of Veterans Affairs ... taking steps to assist Veterans seeking compensation for Post-Traumatic Stress Disorder ... are being addressed vigorously and comprehensively by this administration as we ... Secretary Shinseki. , , The VA is publishing ...
... , , ATLANTA, Aug. 24 ... by the American Diabetes Association (ADA), kicks off in Atlanta on ... F earless A frican-Americans C onnected and E ... also supported by Aetna, educates and empowers African-Americans living with diabetes ...
... EMERYVILLE, Calif., Aug. 24 Nov ... ), a clinical stage company developing non-antibiotic anti-infective compounds for the ... fungal infections, announced today the company has received acceptance to deliver ... Diseases Society of America October 29 - November 1, 2009 in ...
Cached Medicine News:Health News:www.PalliativeDoctors.org: Organization Sheds Light on Hospice and Palliative Care 2Health News:Prostate Net Announces: Major Medical Education Initiative for Patients, Caregivers and Healthcare Professionals 2Health News:Prostate Net Announces: Major Medical Education Initiative for Patients, Caregivers and Healthcare Professionals 3Health News:Secretary Shinseki Moves to Simplify PTSD Compensation Rules 2Health News:Grammy(R)-Nominated R&B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African-Americans to be Victorious in the Face of Diabetes 2Health News:Grammy(R)-Nominated R&B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African-Americans to be Victorious in the Face of Diabetes 3Health News:Grammy(R)-Nominated R&B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African-Americans to be Victorious in the Face of Diabetes 4Health News:NovaBay Pharmaceuticals to Present New Pre-Clinical Data on Lead Anti-Infective Compound for use in Onychomycosis at the 2009 IDSA Annual Meeting 2Health News:NovaBay Pharmaceuticals to Present New Pre-Clinical Data on Lead Anti-Infective Compound for use in Onychomycosis at the 2009 IDSA Annual Meeting 3
... new AquaGuide Ureteral Access Sheath, you can ... access sheath - plus an entirely new ... sheath is designed with a proprietary dual ... second working channel for a variety of ...
Used during the performance of balloon dilation procedures to inflate and deflate the balloon and measure the pressure within the balloon during the procedure. Supplied sterile in peel-open packages....
... Straight Channel; 33 or 42 cm Working ... Ureteroscopes offer a small distal diameter with ... the ureter for diagnosis and treatment. The ... for large operating instruments, mechanical (Lithoclast) or ...
Semi-Rigid Ureteroscope...
Medicine Products: